fundvisualizer.com

Cullen Enhanced Equity Income IENHNX

Performance (before sales charge)

As of 01/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
90.45%
Non-U.S. Stock
8.42%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.13%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

4.62%

Consumer cyclical

0.98%

Financial services

10.77%

Real estate

10.83%

Consumer defensive

16.00%

Health care

14.67%

Utilities

8.51%

Communication services

9.79%

Energy

9.98%

Industrials

9.85%

Technology

3.26%

Top 10 holdings

As of 12/31/2023

PPL Corp
4.42%
VICI Properties Inc Ordinary Shares
4.14%
Medtronic PLC
4.11%
Duke Energy Corp
4.09%
Verizon Communications Inc
4.07%
Merck & Co Inc
3.96%
EOG Resources Inc
3.92%
Conagra Brands Inc
3.67%
Morgan Stanley
3.61%
Bristol-Myers Squibb Co
3.54%
Fund assets

$164.15 Million

Share class

Inst

Morningstar category

Derivative Income

Expense ratio

0.75%

Investment objective

Equity-Income

Documents